Startup signs with Gilead to help more people with arthritis

By Leila Hawkins
Daman has partnered with pharmaceutical giants Gilead and Galapagos to reach more people with rheumatoid arthritis...

Daman, a digital healthcare company based in Denmark, has partnered with pharmaceutical firms Gilead Sciences and Galapagos to reach more people living with rheumatoid arthritis. 

The chronic condition affects around 17.6 million people worldwide, and the WHO estimate that at least 50 per cent of people who develop it are unable to hold down a full-time job within 10 years. 

Daman's new agreement will include 15 global markets, with which they hope to reach more patients living with the illness. The partnership agreement runs until September 2021, with the possibility of extension.

Currently around 13,000 people use Daman's RheumaBuddy app, which lets people rate their symptoms on a daily basis. The app summarises this info and then provides an overview to the patient and their doctor. 

RheumaBuddy also encourages patients to engage with their treatment and speak to other people with the condition. 

Over the next 6 months Daman will be adding new features that have been co-created with patients. These include My Plan & Goal, which will guide healthy habits towards improving quality of life; and a function to help patients collaborate more closely with rheumatologists. 

Andreas Dam, CEO at Daman, said: "There is a huge unmet need among RA patients to give more holistic care offerings. The partnership enables us to take important steps in the direction – to the benefit of patients and society.” 

As well as RheumaBuddy, Daman are the creators of HealthBuddy, a tool that collects patient data via a symptom tracker or diary, and uses machine learning to develop insights and personalised solutions. 

Share

Featured Articles

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Johnson & Johnson takes collaborative approach to tackling the problem of carbon emissions in the global healthcare supply chain

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare

AstraZeneca & Celonis Map out Digital Transformation

Technology & AI